Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer’s Viagra Connect becomes first erectile dysfunction drug available over-the-counter in UK

November 29, 2017
Research and Development, Sales and Marketing MHRA, Pfizer, Viagra Connect, erectile dysfunction, pharma, viagra

Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …

News
mr058666-web

Merck KGaA and Pfizer’s Bavencio fails at Phase 3 in gastric cancer

November 28, 2017
Research and Development Bavencio, Cancer, Merck, Pfizer, pharma

Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary …

News
pfizer-building-logo1web

FDA expands use of Pfizer’s Sutent in kidney cancer

November 17, 2017
Medical Communications, Sales and Marketing Cancer, Kidney cancer, Pfizer, Sutent, pharma

Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …

News

NICE approves Novartis and Pfizer’s rival breast cancer drugs

November 16, 2017
Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical

NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …

News
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017
Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …

News
gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017
Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

News

Pfizer to begin auction of consumer health division next month

October 26, 2017
Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

News
shutterstock_138095450

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017
Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …

News
online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

Appointment

Pfizer sets up its own biotech to develop rejected drugs

September 26, 2017
Manufacturing and Production, Sales and Marketing Pfizer, SpringWorks Therapeutics, biotech, drugs, pharma, pharmaceutical

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …

News

Merck and Pfizer’s joint skin cancer drug gets EU approval

September 21, 2017
Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer

Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …

News

Pfizer receives prostate cancer drug boost with trial results

September 15, 2017
Medical Communications, Research and Development Astellas, Pfizer, Xtandi, biotech, drugs, pharma, pharmaceutical

Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …

News
pfizer-building-logo1web

Pfizer’s drug back on the market after proving safety

September 5, 2017
Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …

News

Taking science and making people feel connected to it

August 21, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026